Auris Medical Provides Business Update and Reports Second Half and Full Year 2020 Financial Results
31 mars 2021 08h30 HE
|
Auris Medical AG
Clinical evaluation of AM-301 nasal spray in allergen protection progressingLaunch of AM-301 expected in selected markets towards the end of second quarter 2021 Phase 2 trial with AM-125 in acute...